$0.96 Earnings Per Share Expected for LifePoint Health, Inc. (NASDAQ:LPNT) This Quarter
Wall Street analysts predict that LifePoint Health, Inc. (NASDAQ:LPNT) will post earnings of $0.96 per share for the current fiscal quarter, Zacks reports. Eight analysts have provided estimates for LifePoint Health’s earnings. The highest EPS estimate is $1.02 and the lowest is $0.87. LifePoint Health reported earnings of $0.94 per share in the same quarter last year, which would indicate a positive year over year growth rate of 2.1%. The firm is scheduled to report its next quarterly earnings results on Friday, October 27th.
On average, analysts expect that LifePoint Health will report full-year earnings of $4.06 per share for the current fiscal year, with EPS estimates ranging from $3.99 to $4.15. For the next financial year, analysts forecast that the company will post earnings of $4.46 per share, with EPS estimates ranging from $4.28 to $4.70. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that cover LifePoint Health.
LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.06. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the prior year, the business posted $0.69 earnings per share. The firm’s revenue was up .2% on a year-over-year basis.
Several equities analysts recently issued reports on the company. BidaskClub lowered LifePoint Health from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $73.00 price target on the stock in a research report on Thursday, July 13th. Royal Bank Of Canada restated a “buy” rating and set a $77.00 price target on shares of LifePoint Health in a research report on Wednesday, July 5th. Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $73.00 to $74.00 in a research report on Tuesday, June 6th. Finally, Morgan Stanley assumed coverage on LifePoint Health in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $65.00 price target on the stock. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $66.18.
In other news, Director Richard H. Evans sold 2,000 shares of LifePoint Health stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $62.88, for a total value of $125,760.00. Following the sale, the director now directly owns 17,718 shares in the company, valued at approximately $1,114,107.84. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Chairman William F. Carpenter III sold 82,347 shares of LifePoint Health stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $64.15, for a total value of $5,282,560.05. Following the completion of the sale, the chairman now owns 504,535 shares in the company, valued at $32,365,920.25. The disclosure for this sale can be found here. Over the last quarter, insiders sold 102,000 shares of company stock worth $6,556,824. Corporate insiders own 7.28% of the company’s stock.
Large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. raised its stake in LifePoint Health by 11,671.9% in the first quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock valued at $245,351,000 after buying an additional 3,714,004 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in LifePoint Health by 0.5% in the first quarter. Dimensional Fund Advisors LP now owns 3,388,830 shares of the company’s stock valued at $221,969,000 after buying an additional 18,327 shares in the last quarter. Vanguard Group Inc. raised its stake in LifePoint Health by 3.8% in the first quarter. Vanguard Group Inc. now owns 3,266,963 shares of the company’s stock valued at $213,986,000 after buying an additional 120,201 shares in the last quarter. Wellington Management Group LLP raised its stake in LifePoint Health by 5.5% in the first quarter. Wellington Management Group LLP now owns 3,257,272 shares of the company’s stock valued at $213,351,000 after buying an additional 168,451 shares in the last quarter. Finally, Alliancebernstein L.P. raised its stake in LifePoint Health by 4.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,943 shares of the company’s stock valued at $113,049,000 after buying an additional 68,886 shares in the last quarter. Institutional investors own 99.27% of the company’s stock.
Shares of LifePoint Health (NASDAQ LPNT) traded up 1.28% during mid-day trading on Tuesday, reaching $59.50. The company had a trading volume of 213,448 shares. LifePoint Health has a 12-month low of $50.60 and a 12-month high of $70.95. The firm has a market capitalization of $2.39 billion, a PE ratio of 13.32 and a beta of 0.86. The stock has a 50 day moving average price of $64.73 and a 200 day moving average price of $62.97.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.